Correlation Between Design Therapeutics and Kiora Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Design Therapeutics and Kiora Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Design Therapeutics and Kiora Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Design Therapeutics and Kiora Pharmaceuticals, you can compare the effects of market volatilities on Design Therapeutics and Kiora Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Design Therapeutics with a short position of Kiora Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Design Therapeutics and Kiora Pharmaceuticals.
Diversification Opportunities for Design Therapeutics and Kiora Pharmaceuticals
-0.02 | Correlation Coefficient |
Good diversification
The 3 months correlation between Design and Kiora is -0.02. Overlapping area represents the amount of risk that can be diversified away by holding Design Therapeutics and Kiora Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kiora Pharmaceuticals and Design Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Design Therapeutics are associated (or correlated) with Kiora Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kiora Pharmaceuticals has no effect on the direction of Design Therapeutics i.e., Design Therapeutics and Kiora Pharmaceuticals go up and down completely randomly.
Pair Corralation between Design Therapeutics and Kiora Pharmaceuticals
Given the investment horizon of 90 days Design Therapeutics is expected to generate 0.82 times more return on investment than Kiora Pharmaceuticals. However, Design Therapeutics is 1.21 times less risky than Kiora Pharmaceuticals. It trades about 0.09 of its potential returns per unit of risk. Kiora Pharmaceuticals is currently generating about 0.0 per unit of risk. If you would invest 251.00 in Design Therapeutics on August 27, 2024 and sell it today you would earn a total of 311.00 from holding Design Therapeutics or generate 123.9% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Design Therapeutics vs. Kiora Pharmaceuticals
Performance |
| Timeline |
| Design Therapeutics |
| Kiora Pharmaceuticals |
Design Therapeutics and Kiora Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Design Therapeutics and Kiora Pharmaceuticals
The main advantage of trading using opposite Design Therapeutics and Kiora Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Design Therapeutics position performs unexpectedly, Kiora Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kiora Pharmaceuticals will offset losses from the drop in Kiora Pharmaceuticals' long position.| Design Therapeutics vs. Monte Rosa Therapeutics | Design Therapeutics vs. Werewolf Therapeutics | Design Therapeutics vs. Ikena Oncology | Design Therapeutics vs. Stoke Therapeutics |
| Kiora Pharmaceuticals vs. Virax Biolabs Group | Kiora Pharmaceuticals vs. Revelation Biosciences | Kiora Pharmaceuticals vs. Quoin Pharmaceuticals Ltd | Kiora Pharmaceuticals vs. Allarity Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Complementary Tools
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |